E-viri
Recenzirano
Odprti dostop
-
Harvey, R. Donald; Miller, Therica M.; Hurley, Patricia A.; Thota, Ramya; Black, Lora J.; Bruinooge, Suanna S.; Boehmer, Leigh M.; Fleury, Mark E.; Kamboj, Jasmine; Rizvi, Mujahid A.; Symington, Banu E.; Tap, William D.; Waterhouse, David M.; Levit, Laura A.; Merrill, Janette K.; Prindiville, Sheila A.; Pollastro, Teri; Brewer, Jamie R.; Byatt, Leslie P.; Hamroun, Leila; Kim, Edward S.; Holland, Nicole; Nowakowski, Grzegorz S.
Cancer, 15 April 2024, Letnik: 130, Številka: 8Journal Article
This commentary is a call to action for a concerted commitment and effort to transform clinical trials and enable people with cancer to participate in clinical trials closer to home. Three key strategies are identified to address major barriers: confront challenges with the interpretation of US Food and Drug Administration Form 1572 requirements (Statement of Investigator); broaden acceptance of local laboratories and imaging centers; and invest in the creation of effective, sustainable partnerships between research centers and local providers.
